Literature DB >> 16774106

Etanercept for chronic progressive cutaneous sarcoidosis.

Chanisada Tuchinda1, Henry K Wong.   

Abstract

Sarcoidosis is a chronic, multisystem, granulomatous disease that has various cutaneous manifestations. Chronic cutaneous sarcoidosis can be difficult to manage. Patients often need systemic corticosteroids as well as other immunosuppressive agents, which may be associated with side effects and long-term complications. We report a 43-year-old patient with chronic progressive cutaneous sarcoidosis unsuccessfully treated with systemic steroid and immunosupressive agents whose cutaneous lesions responded significantly to etanercept as monotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774106

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

1.  Cutaneous sarcoidosis presenting as multiple erythematous macules and patches.

Authors:  Min Ju Kang; Hei Sung Kim; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

2.  Rare scar sarcoidosis: A case report.

Authors:  Sha Zhao; Qin Wang; Beibei Cheng; Xiao-Fang Zhu
Journal:  Exp Ther Med       Date:  2017-02-15       Impact factor: 2.447

3.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

4.  Biologics in dermatology.

Authors:  David Chandler; Anthony Bewley
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.